Pfizer says its coronavirus vaccine is safe and 95% effective and that it will seek regulatory review within days

by

Pfizer’s experimental coronavirus vaccine had already shown promise in an early analysis. An application for emergency authorization will be submitted “within days,” the company said.

View original article
Contributor: Carolyn Y. Johnson